434 related articles for article (PubMed ID: 23699064)
21. Heteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections.
He J; Jia X; Yang S; Xu X; Sun K; Li C; Yang T; Zhang L
Int J Antimicrob Agents; 2018 Mar; 51(3):413-421. PubMed ID: 29127047
[TBL] [Abstract][Full Text] [Related]
22. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
[TBL] [Abstract][Full Text] [Related]
23. Intrahospital spread of carbapenem-resistant Pseudomonas aeruginosa in a University Hospital in Florianópolis, Santa Catarina, Brazil.
Scheffer MC; Bazzo ML; Steindel M; Darini AL; Clímaco E; Dalla-Costa LM
Rev Soc Bras Med Trop; 2010; 43(4):367-71. PubMed ID: 20802932
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
[TBL] [Abstract][Full Text] [Related]
25. Laboratory based antimicrobial resistance surveillance for Pseudomonas aeruginosa blood isolates from South Africa.
Singh-Moodley A; Duse A; Naicker P; Kularatne R; Nana T; Lekalakala R; Mbelle N; Dawood H; Swe Swe Han K; Ramjathan P; Bhola P; Whitelaw A; Perovic O
J Infect Dev Ctries; 2018 Aug; 12(8):616-624. PubMed ID: 31958323
[TBL] [Abstract][Full Text] [Related]
26. Comparative evaluation of colistin broth disc elution (CBDE) and broth microdilution (BMD) in clinical isolates of Pseudomonas aeruginosa with special reference to heteroresistance.
Banerjee T; Adwityama A; Sharma S; Mishra K; Prusti P; Maitra U
Indian J Med Microbiol; 2024; 47():100494. PubMed ID: 37890411
[TBL] [Abstract][Full Text] [Related]
27. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
28. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
29. Dissemination of metallo-β-lactamase in Pseudomonas aeruginosa isolates in Egypt: mutation in blaVIM-4.
Hashem H; Hanora A; Abdalla S; Shaeky A; Saad A
APMIS; 2017 May; 125(5):499-505. PubMed ID: 28295668
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
[TBL] [Abstract][Full Text] [Related]
31. Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program.
Ribeiro J; Mendes RE; Domingos R; França E; Silbert S; Jones RN; Sader HS
J Chemother; 2006 Oct; 18(5):461-7. PubMed ID: 17127220
[TBL] [Abstract][Full Text] [Related]
32. Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa.
Atrissi J; Milan A; Bressan R; Lucafò M; Petix V; Busetti M; Dolzani L; Lagatolla C
Microbiol Spectr; 2021 Oct; 9(2):e0118621. PubMed ID: 34585948
[TBL] [Abstract][Full Text] [Related]
33. [Molecular characterization of carbapenem-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from blood cultures from children and teenagers with cancer].
Fernandes TA; Pereira CA; Petrili AS; Pignatari AC
Rev Soc Bras Med Trop; 2010; 43(4):372-6. PubMed ID: 20802933
[TBL] [Abstract][Full Text] [Related]
34. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
[TBL] [Abstract][Full Text] [Related]
35. Carbapenem-Resistant Pseudomonas aeruginosa in Chronic Lung Infection: Current Resistance Profile and Hypermutability in Patients with Cystic Fibrosis.
Almeida MM; Freitas MT; Folescu TW; Firmida MC; Carvalho-Assef APD; Marques EA; Leão RS
Curr Microbiol; 2021 Feb; 78(2):696-704. PubMed ID: 33404752
[TBL] [Abstract][Full Text] [Related]
36. First report of novel genetic array aacA4-blaIMP-25-oxa30-catB3 and identification of novel metallo-β-lactamase gene blaIMP25: A Retrospective Study of antibiotic resistance surveillance on Psuedomonas aeruginosa in Guangzhou of South China, 2003-2007.
Yu G; Wen W; Peters BM; Liu J; Ye C; Che Y; Liu J; Cao K; Xu Z; Shirtliff ME
Microb Pathog; 2016 Jun; 95():62-67. PubMed ID: 26997650
[TBL] [Abstract][Full Text] [Related]
37. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
[TBL] [Abstract][Full Text] [Related]
38. Clonal Distribution and Its Association With the Carbapenem Resistance Mechanisms of Carbapenem-Non-Susceptible
Kim N; Ko SY; Park SY; Kim SY; Lee DE; Kwon KT; Kim YK; Lee JC
Ann Lab Med; 2024 Sep; 44(5):410-417. PubMed ID: 38433574
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
[TBL] [Abstract][Full Text] [Related]
40. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
Ocampo-Sosa AA; Cabot G; Rodríguez C; Roman E; Tubau F; Macia MD; Moya B; Zamorano L; Suárez C; Peña C; Domínguez MA; Moncalián G; Oliver A; Martínez-Martínez L;
Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
